Practical Issues for Pharmacists
A coalition of more than 40 health insurers recently announced plans for prior authorization reform. Read More ›
By Sara Erickson, PharmD, BCACP; Anna Bartoo, PharmD, BCPS; Amy Wallingford, PharmD; Susan Wescott, MBA, RPh; Chelsee Jensen, PharmD, BCPS, P-RCM, RPh
Biosimilars offer a significant opportunity for cost-savings yet present logistical hurdles for optimal implementation. Biosimilar savings nationwide are estimated to be $54 billion from 2017 to 2026, but these savings hinge on industry, regulatory, and policy changes to strengthen competition and sustainability in the biosimilar marketplace. Read More ›
By Joseph Haroney, PharmD, BCPS; Amanda Kogelman, PharmD, BCOP; Chelsea Palmer, CPhT-Adv, CSPT; Aimee Cloud, PharmD, BCOP; Daniel Kroll, PharmD
Annual US spending on oral cancer drugs has surpassed $947 million and is expected to increase 12% to 15% annually through 2027. In many cases, a significant portion of these funds come directly from patients. The out-of-pocket costs for the top 54 oral chemotherapy agents in 2019 were projected to exceed $10,000 per fill annually for patients enrolled in Medicare Part D plans. Read More ›
On July 19, 2023, an EF3 tornado touched down in Rocky Mount, NC, badly damaging a Pfizer drug manufacturing facility that is responsible for producing nearly 25% of Pfizer’s sterile injectable medicines used in US hospitals. Read More ›
By Karen Blum
Early last year, Jerome Wohleb, PharmD, MBA, FASHP, Pharmacy Services Director, Bryan Medical Center, Lincoln, NE, faced a dilemma. A Nebraska Pharmacy Workforce Survey revealed a high level of burnout among pharmacists in the aftermath of the COVID-19 pandemic. Read More ›
Own-occupation disability insurance is often a pharmacist’s best line of defense when protecting his or her income from a disabling event. Read More ›
The American Society of Health-System Pharmacists (ASHP) Foundation's Pharmacy Forecast, now in its fourth edition, serves to improve the effectiveness of leaders in hospital and health-system pharmacy practice. Read More ›
By Wayne Kuznar
Washington, DC-The role of oncology specialty pharmacy in helping to streamline medication delivery for patients with cancer was the subject of a panel discussion that took place at the Fifth Annual Conference of the Association for Value-Based Cancer Care. Read More ›
The National Prescription Drug Take-Back addresses a vital public safety and public health issue. Many patients are not aware that the medicines in their cabinets are highly susceptible to diversion, misuse, and abuse. Read More ›
Adherence to certain strategies can aid pharmacists in successful navigation of our increasingly collaborative healthcare landscape. Read More ›